Medical Communications

Showing 15 posts of 6411 posts found.

Pfizer’s COVID-19 vaccine under FDA’s examination following new research into adverse side effects

January 13, 2023 Medical Communications

The FDA, along with Taiwanese medical institutions, have been evaluating Pfizer’s mRNA COVID-19 vaccine, questioning the CDC’s omission of known …

Diabeloop and EOFlow team up to develop an automated insulin device

January 13, 2023 Medical Communications

Diabeloop, a medical device company focused on automated diabetes treatment solutions, and South Korea-based EOFlow have joined forces to offer …

BD showcase new-generation robotic track system for microbiology labs

January 12, 2023 Medical Communications

US-based Becton, Dickinson and Company (BD) has revealed new-generation robotic track system for its BD Kiestra microbiology laboratory solution which …

FDA clears first ACL reconstruction device for use in paediatric patients

January 11, 2023 Medical Communications

The FDA has cleared the ACL TightRope® II implant to treat torn knee ligaments in children and adolescents. The implant …

BioNTech acquires AI company InstaDeep for £562m

January 11, 2023 Medical Communications

Germany-based BioNTech has acquired UK AI start up InstaDeep for £562m after a multi-year partnership. The acquisition is part of …

Insilico Medicine shares positive topline results of phase 1 trial of AI-designed drug for AI-discovered target

January 10, 2023 Medical Communications

Clinical stage AI-driven drug R&D company, Insilico Medicine, has announced positive topline results from its phase 1 trial assessing the …

FDA issues Emergency Use Authorisation for BD and CerTest Biotec’s Monkeypox PCR test

January 10, 2023 Medical Communications

US medical technology company BD and Spanish biotechnology company CerTest Biotec have joined forces to develop a real-time Monkeypox test …

NHS to offer artificial pancreas to type 1 diabetes patients

January 10, 2023 Medical Communications

The NHS will soon be offering an artificial pancreas to more than 100,000 people with type 1 diabetes across England …

BioNTech and UK Government announce strategic partnership to provide mRNA cancer immunotherapies

January 6, 2023 Medical Communications

German biotech company BioNTech and the UK Government have signed a Memorandum of Understanding (MoU) which will accelerate clinical trials …

Withings announces hands-free connected in-home urine lab

January 6, 2023 Medical Communications

Connected health firm Withings has unveiled its new in-home biomarker analysis platform U-Scan. It is hoped the device will utilise …

Synaffix Enters License Agreement with Amgen to Build Next Generation ADCs

January 5, 2023 Medical Communications

AMSTERDAM, THE NETHERLANDS, 5 January 2023 — Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform technology for …

FDA accepts application for nirsevimab as first protective option for RSV in infants

January 5, 2023 Medical Communications

The FDA has accepted an application for nirsevimab as the first protective option to combat respiratory syncytial virus (RSV) disease …

FDA expands access to abortion pills

January 4, 2023 Medical Communications

Following new rules from the FDA under the Biden administration, patients can now obtain the abortion pill mifepristone from retail …

Novartis pays $245m to settle Exforge generic pay-for-delay lawsuit

January 4, 2023 Medical Communications

Swiss pharma company Novartis will settle a classic generic pay-for-delay legal battle with direct purchasers, indirect purchasers and retailers regarding …

FDA grants Breakthrough Device Designation for Burning Rock’s multi-cancer detecting test

January 4, 2023 Medical Communications

Burning Rock, a Chinese biotech company which focuses on the applications of next-generation sequencing (NGS) technology in the field of …
The Gateway to Local Adoption Series

Latest content